SCHEMBL6700133

SCHEMBL6700133

Cc1cc2ccccc2n1Cc1ccc(-c2ccccc2Br)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 2/20 0.56
HDAC1 Q13547 1/20 0.56
HDAC2 Q92769 1/20 0.56
HDAC8 Q9BY41 1/20 0.56
HDAC9 Q9UKV0 1/20 0.56
PPARG P37231 7/20 0.47
AGTR1 P30556 1/20 0.45
AGTR2 P50052 1/20 0.45
PTGDR2 Q9Y5Y4 2/20 0.44
PTGS2 P35354 1/20 0.43
MAPT P10636 2/20 0.42
MEN1 O00255 1/20 0.42
NPC1 O15118 1/20 0.42
ALDH1A1 P00352 1/20 0.42
S100A4 P26447 1/20 0.42
RAB9A P51151 1/20 0.42
KMT2A Q03164 1/20 0.42
PPARA Q07869 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2824971 0.80 HDAC6 (0.64) HDAC6HDAC1HDAC2HDAC8HDAC9
SCHEMBL30049411 0.79 HDAC1 (0.62) HDAC6HDAC1HDAC2HDAC8HDAC9
SCHEMBL6821030 0.79 HDAC1 (0.62) HDAC6HDAC1HDAC2HDAC8HDAC9
SCHEMBL6086266 0.78 HDAC1 (0.62) HDAC6HDAC1HDAC2HDAC8HDAC9
SCHEMBL20853225 0.78 HDAC1 (0.62) HDAC6HDAC1HDAC2HDAC8HDAC9
SCHEMBL6695593 0.77 GALR3 (0.71) HDAC6HDAC1PPARGMAPTNPC1
SCHEMBL6695297 0.77 HDAC1 (0.46) HDAC6HDAC1HDAC2HDAC8HDAC9
SCHEMBL6087324 0.77 HDAC1 (0.60) HDAC6HDAC1HDAC2HDAC8HDAC9
SCHEMBL6821068 0.77 HDAC1 (0.50) HDAC6HDAC1HDAC2HDAC8HDAC9
SCHEMBL6225425 0.76 GALR3 (0.69) HDAC6HDAC1PPARGMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040229874-A1 5HT7 Antagonists and inverse agonists PFIZER INC. 2004-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040229874-A1 5HT7 Antagonists and inverse agonists HTR7, HTR1A, HTR1B HDAC6 1841/4885HDAC1 2282/4885HDAC2 2178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.